Part of the work will focus on using deep learning — the technique that has brought the biggest recent advances in AI — to improve development of new medicines, the Los Angeles Times reports. Also in industry news: new technology for pictures of the heart, Biogen announces a new R&D chief, Bayer appoints a prominent agricultural expert to its board, and a primer on the problems that led drug stores to pull Zantac from the shelves.

from Kaiser Health News https://ift.tt/2ox2QlU

0 comments:

Post a Comment

Popular Posts